Eisai to Present Latest Data on Lemborexant at the 37th Annual Sleep 2023 Meeting Eisai Jun 02, 2023 11:20 HKT/SGT Read More
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China China Medical System Holdings Ltd. May 30, 2023 23:00 JST Read More
アバンセ・クリニカルがASCO & BIO 2023に参加 初期段階のオンコロジー試験はより精緻化、より多くの患者を必要とする Avance Clinical May 30, 2023 20:00 JST Read More
TANAKA Precious Metals to Exhibit at "Medtec China 2023" Medical Device Design and Manufacturing Exhibition, to be Held in Suzhou, China TANAKA PRECIOUS METAL GROUP Co., Ltd. May 30, 2023 14:00 HKT/SGT Read More
TANAKA Precious Metals to Exhibit at "Medtec China 2023" Medical Device Design and Manufacturing Exhibition, to be Held in Suzhou, China TANAKA PRECIOUS METAL GROUP Co., Ltd. May 30, 2023 14:00 HKT/SGT Read More
Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer Olympus May 29, 2023 14:00 HKT/SGT Read More
Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer Olympus May 29, 2023 14:00 HKT/SGT Read More
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma Eisai May 26, 2023 13:15 HKT/SGT Read More
Eisai's Initiatives for Developing New Medicines for Neglected Tropical Diseases and Malaria Eisai May 25, 2023 20:02 HKT/SGT Read More
Eisai Delivers New Data and Highlights Continued Progress of Oncology Portfolio and Pipeline at ASCO 2023 Eisai May 24, 2023 17:03 HKT/SGT Read More
エーザイ、抗アミロイドβプロトフィブリル抗体「レカネマブ」について、英国（北アイルランドを除く）において早期アルツハイマー病に係る販売承認申請を提出 Eisai May 22, 2023 09:00 JST Read More
Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Great Britain Eisai May 20, 2023 09:20 HKT/SGT Read More
Taiwan's First Heavy Ion Therapy System Starts Treatment at Taipei Veterans General Hospital Hitachi, Ltd. May 18, 2023 10:56 HKT/SGT Read More
Fujitsu launches Biodrug Design Accelerator platform to accelerate peptide drug discovery research Fujitsu Ltd May 18, 2023 10:12 HKT/SGT Read More
Fujitsu, Kyoto University, and Chordia Therapeutics launch AI trials to discover biomarkers for new cancer drugs Fujitsu Ltd May 17, 2023 09:28 HKT/SGT Read More
エーザイ、臨床第III相Clarity AD試験データを用いた、日本における「レカネマブ」の社会的価値について、査読学術専門誌Neurology and Therapy誌に掲載 Eisai May 17, 2023 08:30 JST Read More
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer's Disease Eisai May 16, 2023 08:27 HKT/SGT Read More
Fujitsu conducts project with Takeda and National Cancer Center Japan to analyze and visualize of patient journey with ovarian cancer Fujitsu Ltd May 12, 2023 09:29 HKT/SGT Read More
